🔎 Trials Near Me

Hjem › T-celle-lymfom › Texas

T-celle-lymfom kliniske forsøg i Texas

9 studier for T-celle-lymfom søger deltagere på steder i Texas.

Byer i Texas

Officiel studietekst (engelsk)

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

  • Texas Children's Hospital, Houston
RekruttererObservationsstudie
Alder 0 til 38 · Alle køn · Opdateret 1. okt. 2026 · NCT06131801

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

  • UT Southwestern Medical Center, Dallas
  • MD Anderson Cancer Center, Houston
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06561048

Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms

  • The University of Texas M. D. Anderson Cancer Center, Houston
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT07382817

Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)

  • Natera, Inc., Austin
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT07750886

CD4CAR for CD4+ Leukemia and Lymphoma

  • The University of Texas MD Anderson Cancer Center, Houston
RekruttererFase 1
Alder 12 og opefter · Alle køn · Opdateret 24. jun. 2026 · NCT03829540

A Registry for People With T-cell Lymphoma

  • MD Anderson Cancer Center (Data Collection Only), Houston
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 20. maj 2026 · NCT05978141

MB-105 in Patients With CD5 Positive T-cell Lymphoma

  • Baylor College of Medicine, Houston
  • MD Anderson Cancer Center, Houston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 3. okt. 2025 · NCT06534060

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

  • The University of Texas MD Anderson Cancer Center, Houston
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2025 · NCT04234048

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • University of Texas, Southwestern, Dallas
  • Cook Children's Hospital, Fort Worth
  • Texas Children's Hospital/Baylor College of Medicine, Houston
RekruttererFase 1
Alder 1 til 21 · Alle køn · Opdateret 6. dec. 2024 · NCT05476770

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.